CHIMERIX INC. - COMMO
0.9351
07-November-24 14:59:42
15 minutes delayed
Stocks
-0.0749
-7.42%
Today's range
0.9079 - 1.0500
ISIN
N/A
Source
NASDAQ
-
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
28 Feb 2023 15:05:01 By Nasdaq GlobeNewswire
-
23 Feb 2023 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
08 Dec 2022 16:00:00 By Nasdaq GlobeNewswire
-
Chimerix Responds to Rubric Capital Management
10 Nov 2022 15:30:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
03 Nov 2022 06:00:02 By Nasdaq GlobeNewswire
-
27 Oct 2022 15:30:00 By Nasdaq GlobeNewswire
-
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
26 Sep 2022 15:05:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
29 Aug 2022 09:45:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update
08 Aug 2022 15:01:00 By Nasdaq GlobeNewswire
-
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Wedbush PacGrow Healthcare Conference
02 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
01 Aug 2022 15:01:00 By Nasdaq GlobeNewswire
-
24 Jun 2022 09:06:16 By Nasdaq GlobeNewswire
-
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23 Jun 2022 08:15:16 By Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies Global Healthcare Conference
01 Jun 2022 15:30:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright Global Investment Conference
17 May 2022 15:15:00 By Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
16 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
16 May 2022 05:30:00 By Nasdaq GlobeNewswire